Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC38
TNBC
Basal B
Trametinib
MEK
MAPK
7854.05
uM
inf
inf
0.8124 0.8124 0.0000 0.0613
-0.0181
1.0664
HCC38
TNBC
Basal B
Trametinib
MEK
MAPK
9453.012
uM
inf
inf
0.9034 0.9034 0.0000 -0.0001
0.4116
1.2055
HCC38
TNBC
Basal B
Trametinib
MEK
MAPK
9469.024
uM
20.76870
18.58140
0.7090 0.2134 4.9999 0.0060
0.8310
1.0746
HCC38
TNBC
Basal B
Trastuzumab
HER2
ErbB
9469.026
uM
inf
inf
0.8380 0.8380 0.0000 0.0264
0.4874
1.2092
HCC38
TNBC
Basal B
Trastuzumab
HER2
ErbB
10268.122
uM
3.49450
1.70630
0.4865 0.4861 4.9935 0.0343
0.6574
0.6345
HCC38
TNBC
Basal B
Trichostatin A
HDAC
HDAC
10418.065
uM
7.46270
11.54670
-0.9677 -0.9653 2.4633 0.9555
0.9917
0.9401
HCC38
TNBC
Basal B
Trichostatin A
HDAC
HDAC
7469.065
uM
6.6810
8.9210
-0.7039 -0.6298 2.8193 0.7864
0.9967
2.0006
HCC38
TNBC
Basal B
Trichostatin A
HDAC
HDAC
7468.065
uM
5.63450
8.75860
-0.8821 -0.8543 2.2588 0.9332
0.9979
1.5219
HCC38
TNBC
Basal B
Triciribine
AKT
AKT
7468.074
uM
0.29265
0.28992
0.0167 0.0229 5.0000 0.4113
0.8951
1.5027
HCC38
TNBC
Basal B
Triciribine
AKT
AKT
7469.074
uM
1.93740
2.47520
0.0995 -0.0812 0.6143 0.2290
0.9851
1.9843
HCC38
TNBC
Basal B
Valproic acid
HDAC
HDAC
10578.143
uM
549.94360
1000.00000
-0.8934 -0.6490 1.3915 0.3368
0.9410
1.6935
HCC38
TNBC
Basal B
Valproic acid
HDAC
HDAC
11850.143
uM
675.71620
1000.00000
-0.7673 -0.5833 1.9725 0.3298
0.9647
2.1044
HCC38
TNBC
Basal B
Vinorelbine
TUBB
TUBB
7854.018
uM
0.01793
0.03910
-0.9604 -0.5785 0.9861 0.8649
0.9206
1.2298
HCC38
TNBC
Basal B
Vinorelbine
TUBB
TUBB
9453.125
uM
0.00620
0.01677
-0.9551 -0.7105 0.8888 1.2796
0.9343
1.2351
HCC38
TNBC
Basal B
Vinorelbine
TUBB
TUBB
9028.018
uM
0.00890
0.01030
-0.9593 -0.5379 4.9999 1.0110
0.9456
1.0242
HCC38
TNBC
Basal B
Vorinostat
HDAC
HDAC
10418.065
uM
12.43020
34.13860
-0.9682 -1.0000 1.0874 1.0503
0.9666
0.9401
HCC38
TNBC
Basal B
Vorinostat
HDAC
HDAC
7468.065
uM
34.54050
65.85140
-0.8710 -0.8811 1.5746 0.8521
0.9963
1.5219
HCC38
TNBC
Basal B
Vorinostat
HDAC
HDAC
7469.065
uM
56.36950
98.13920
-0.6634 -0.6778 1.5453 0.6859
0.9993
2.0006
HCC38
TNBC
Basal B
XRP44X
ELK3
MAPK
11850.157
uM
1.56040
1.50450
0.0343 0.0323 1.8299 0.3682
0.9769
2.0943
HCC38
TNBC
Basal B
XRP44X
ELK3
MAPK
10578.139
uM
2.01990
2.47790
-0.2396 -0.2200 1.7843 0.3676
0.9952
1.6434
HCC38
TNBC
Basal B
Z-Leu-Leu-Norvalinal
Proteasome
Proteasome
14212.189
uM
0.57153
0.70512
-0.9392 -0.9291 5.0000 0.6807
0.9965
1.6254
HCC38
TNBC
Basal B
Z-Leu-Leu-Norvalinal
Proteasome
Proteasome
14616.189
uM
0.54715
0.67584
-0.9421 -0.9367 4.9967 0.6858
0.9977
1.4258
HCC38
TNBC
Basal B
ZM-447439
AURK
AURK
10578.138
uM
0.49764
0.43283
0.0459 0.1397 2.3483 0.4024
0.9609
1.7866
HCC38
TNBC
Basal B
ZM-447439
AURK
AURK
11850.16
uM
0.41442
0.46153
-0.2903 -0.1814 2.8754 0.5113
0.9776
1.8797
HCC70
TNBC
Basal A
(Z)-4-Hydroxytamoxifen
ESR1
7860.016
uM
23.70830
7.16980
0.1286 0.4987 5.0000 0.1399
0.5753
0.6145